Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Teva Marion Copaxone launch price of $922 per month AWP is in mid-range of MS therapies.

Executive Summary

TEVA MARION COPAXONE LAUNCH PRICE OF $922.98 AWP PER MONTH places it in the mid-range of the marketed interferon beta multiple sclerosis therapies. Once-daily injectable Copaxone (glatiramer) is supplied in 32-vial packs of 20 mg each and includes an administration materials package. According to the "Red Book," Biogen's weekly injectable Avonex (interferon beta-1a) costs $852 AWP for a kit including four 30 mcg vials and administration materials, while Berlex' Betaseron (interferon beta-1b), which is dosed every other day, costs $1,080 AWP for a package of 15 vials of .3 mg each.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS030048

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel